EUVIMEDEUVIMED entdecken
Crossref

Longitudinal antigenic and seroepidemiological analyses of parechovirus A1 in Yamagata, Japan

Katsumi Mizuta iD, Tsutomu Itagaki iD, Fumio Katsushima, Yuriko Katsushima, Mika Sasaki, Kenichi Komabayashi iD, Yoko Ikeda, Yoko Aoki, Yoko Matsuzaki iD

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Katsumi Mizuta und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan. Hauptthemen laut MEDLINE: Parechovirus, Viruses, Influenza, Human. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To investigate the antigenic changes in parechovirus 1 (PeVA1), seroepidemiological analyses were performed against the Harris strain (Harris), isolated in 1956, and PeVA1/Yamagata.JPN/2021‐4785, isolated in 2021, using immune sera and 207 and 237 human serum specimens collected in 2021 and 1976, respectively. Although rabbit immune sera showed the highest neutralization antibody (NT‐Ab) titers against the immunized viruses at 1:12 800–1:102 400, they were cross‐reactive at 1:400–1:800. All 62 Yamagata isolates obtained between 2001 and 2021 (Yamagata strains), belonging to phylogenetic lineage 1B, reacted more strongly (mostly 4–64 times) to antiserum against PeVA1/Yamagata.JPN/2021‐4785 than to antiserum against Harris, belonging to phylogenetic lineage 1 A. Human serum specimens obtained in 2021 showed higher NT‐Ab titers against PeVA1/Yamagata.JPN/2021‐4785, whereas those obtained in 1976 had similar NT‐Ab titers against both strains. These findings suggested that Yamagata strains and Harris were antigenically cross‐reactive, although there were differences. There are still high NT‐Abs titers present against Harris in 2021 in particular, indicating that PeVA1 has been in circulation with high immunity in the population. In conclusion, this study suggested that PeVA1 has been endemically perpetuated with only minor antigenic changes as well as with high immunity over several decades in the community.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ParechovirusVirusesInfluenza, HumanAnimalsHumansRabbitsJapanPhylogenyImmune Sera

Stichwörter der Autor:innen

antigenic analysisechovirus 22parechovirus A1seroepidemiology

Substanzen

Immune Sera

Autor:innen und Institutionen

  • Department of Microbiology, Yamagata Prefectural Institute of Public Health, Yamagata, Japan.
  • Yamanobe Pediatric Clinic, Yamagata, Japan.
  • Katsushima Pediatric Clinic, Yamagata, Japan.
  • Department of Infectious Diseases, Faculty of Medicine, Yamagata University, Yamagata, Japan.

ORCID-Profile: Katsumi Mizuta, Tsutomu Itagaki, Kenichi Komabayashi, Yoko Matsuzaki

Zitieren

APA

Mizuta, K., Itagaki, T., Katsushima, F., Katsushima, Y., Sasaki, M., Komabayashi, K., Ikeda, Y., Aoki, Y., & Matsuzaki, Y. (2023). Longitudinal antigenic and seroepidemiological analyses of parechovirus A1 in Yamagata, Japan. Journal of Medical Virology. https://doi.org/10.1002/jmv.28696

Vancouver

Mizuta K, Itagaki T, Katsushima F, Katsushima Y, Sasaki M, Komabayashi K, et al. Longitudinal antigenic and seroepidemiological analyses of parechovirus A1 in Yamagata, Japan. Journal of Medical Virology. 2023. doi:10.1002/jmv.28696

BibTeX
@article{Mizuta2023,
  author = {Mizuta, Katsumi and Itagaki, Tsutomu and Katsushima, Fumio and Katsushima, Yuriko and Sasaki, Mika and Komabayashi, Kenichi and Ikeda, Yoko and Aoki, Yoko and Matsuzaki, Yoko},
  title = {Longitudinal antigenic and seroepidemiological analyses of parechovirus A1 in Yamagata, Japan},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28696}
}
Kostenlos starten →